1.Current status of Atopic dermatitis in Mongolia: (2015-2025)
Oyuntsatsral B ; Dulguunkharaa B ; Anujin M ; Badamsuren G ; Narantuya B ; Tsendsuren S
Mongolian Journal of Health Sciences 2026;94(4):102-106
Background:
Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by epidermal barrier dysfunction, immune dysregulation, and significant clinical burden. In Mongolia, research on AD has increased over the past decade; however, findings remain fragmented across various areas.
Aim:
To synthesize evidence from studies conducted in Mongolia over the last 10 years regarding the pathogenesis, clinical features, diagnosis, and treatment of atopic dermatitis.
Materials and Methods:
A narrative review was conducted, including original studies on Mongolian populations published within the last decade. Studies addressing skin barrier function, immunological mechanisms, genetic factors, environmental exposures, clinical severity, diagnostic tools, and treatment approaches were included.
Results:
The study findings show that genetic studies identified polymorphisms in the filaggrin gene and, more recently, mutations in the GCDH gene, suggesting these are linked to AD severity and allergen sensitization. Research on the immunopathogenesis of AD revealed that Th2-type cytokines, especially IL-3 and IL-4, are associated with pruritus and disease severity. Additionally, decreased skin hydration and increased transepidermal water loss in individuals with AD were linked to greater disease severity. Disease severity was evaluated using the SCORAD, EASI, and POEM tools, with most studies reporting that mild-to-moderate AD was most common. Clinically, symptoms like pruritus and sleep disturbances were evident. Additionally, clinical severity was associated with laboratory markers, particularly total IgE levels. The high rate of sensitization to inhalant and food allergens suggests that extrinsic atopic dermatitis (AD) may be common in the Mongolian population. In treatment studies using locally relevant natural products in Mongolia, such as seabuckthorn oil and Shargaljuut mineral spring spray, these products were associated with clinical improvement, suggesting they could serve as additional therapeutic options.
Conclusion
Research on atopic dermatitis in Mongolia has progressed in several areas; however, the current evidence remains limited and is mostly based on cross-sectional, small-sample, single-center, hospital-based studies. Therefore, there is a need for future comprehensive studies that are multicenter, long-term, and involve larger populations.
2.ЭЛЭГНИЙ АРХАГ ҮРЭВСЭЛ, ЦИРРОЗЫН ҮЕД ЭЛЭГНИЙ ФИБРОЗЫН ЗЭРГИЙГ ХАТГАЛТЫН БУС СИЙВЭНГИЙН БИОМАРКЕРИЙН АРГААР ХАРЬЦУУЛАН СУДАЛСАН ДҮНГЭЭС
Ariunzaya B ; Badamsuren D ; Ulzmaa G ; Baasansuren B ; Nasantogtokh D ; Suvdaa B
Innovation 2017;11(2):16-18
BACKGROUND. HCV-infected and obesity related liver diseases are leading to increases
in the prevalence of advanced liver disease. So, studying liver disease, especially liver
fibrosis is crucial issue of today. In Mongolia digestive system disease is second causation
of non-communicable disease. Therefrom in last years hepatocellular carcinoma is most
common malignancy, first of all cancers in Mongolia. In response to acute or chronic liver
injury, hepatic fibrosis is the accumulation of extracellular matrix and ultimately leads to
cirrhosis. Cirrhosis is the end-stage of fibrosis, resulting in nodule formation that may lead
to altered hepatic function and blood flow. Defining the phase of liver fibrosis is crucial
for therapeutic choice prognosis, important role in monitoring treatment. At the present
time, use of direct and undirect biomarkers methods could be recommended for liver
fibrosis stage. The aim of this study is to determine liver fibrosis stage and to compare
undirect biomarkers in chronic viral hepatitis, cirrhosis. METHODS: 630 cases by chronic
viral hepatitis and cirrhosis at third central hospital in Mongolia from retrospectively reviewed
and analysed. The clinical data including AST, ALT, platelet count and INR were
recorded. APRI, FIB-4, AAR and FibroQ were calculated. RESULT: From all, males 42.06%
and females 57.94%, with mean age of 55.35±24.0, in 130 cases with chronic viral hepatitis
and 500 cases with cirrhosis. In cases of cirrhosis, mean value of platelet count, ALT,
AST, INR was 120.54±73.53, 104.55±500.22, 111.68±279.97, 2.19±10.45, respectively. And in
cases of chronic viral hepatitis platelet count mean value was 211.18±6.42.
APRI was detected <0.5 cutoff value (F0-F1) 11.7% non-fibrosis, 0.5-1.5 score (F2-F3) 27.5%
fibrosis, >1.5 cutoff value (F4) 60.8% cirrhosis. FIB-4 was determined <1.45 cutoff value
(F0-F1) 14.8% non-fibrosis, 1.45-3.25 score (F2-F3) 15.7% fibrosis, >3.25 cutoff value (F4)
69.5%, AAR was showed <0.4 cutoff value (F0-F1) 2.3% non-fibrosis, 0.4-1 score (F2-F3)
30.2% fibrosis, >1 cutoff value (F4) 67.5%. And FibroQ was detected <0.6 cutoff value (F0-
F1) 0.5% non-fibrosis, 0.6-2.6 score (F2-F3) 6% fibrosis, cutoff value 2.6< (F4) 93.5 cirrhosis.
In study liver fibrosis staging by APRI, AAR, FIB-4 and FibroQ score system, AAR was determined
fibrosis in 190 cases. CONCLUSION: Recorded data ALT, AST, INR in cases of
cirrhosis were detected 104.55±500.22, 111.68±279.97, 2.19±10.45, respectively. And in
cases of chronic hepatitis platelet count mean value was 211.18±6.42. APRI, AAR, FIB-4,
FibroQ was determined fibrosis 27.5%,30.16%,15.71% and 6.03%, respectively.
3.Rhubarb (Rheum Undulatum.l) extract anti proliferative and anti cancer activities in B16F10 murine melanoma cells
Duuriimaa О ; Purevjargal N ; Badamsuren B ; Odontuya B ; Baatartsogt O
Mongolian Medical Sciences 2017;179(1):45-51
Background:
There are 13283 people per 100 000 were diagnosed with skin cancer in 2016. Skin cancer is reported not widely in Mongolia. However, melanoma and non-melanoma new case are gradually increasing since 2010. Rhubarb is an old and well-known traditional Mongolian herbal medicine. Rhubarb is rich of bioactive compounds and widely distributed around Mongolia. People are still using Rhubarb as in food consumption and traditional medical treatments. Yet, there is not reported any therapeutic effect of rhubarb based on scientific research.PurposeTo investigate the anti-cancer activities of rhubarb (Rheum undulatum.L), a new herbal preparation from Mongolia, on B16F10 cells
Material and Methods:
The shoot of rhubarb was soaked with 40% ethanol and methanol. Murine melanoma B16F10 and RAW264.7 macrophage cell lines were purchased from the American Type Culture Collection (ATCC). Cell viability was determined CCK-8 assay. The antimigratory effect of Rhubarb (50-400 μg/μl) was investigated by a wound healing assay for 12 hours. Apoptosis was then evaluated by Western blot analysis. All experiments conducted at Core laboratory of Mongolian national university of medical sciences and Genomics laboratory of Mongolian university of life sciences from November 2015 to February 2017.
Results:
Ethanol and methanol extract of rhubarb inhibited the proliferation of B16F10 and RAW264.7 cells. In WHMA, cell migration was gradually decreased by concentrate dependent groups compare to the control group. Furthermore, protein expression PARP, Akt, BCL2, BAX and mTOR was investigated. BAX, Akt were down-regulated by rhubarb extraction as expected. DNA fragmentation assay have shown a dose dependent increase in the fragmentation of the DNA signifying apoptotic changes in the R.u extract treated B16F10 cells.
Conclusion
Rhubarb (Rheum undulatum.L) shows promising anti-cancer activity and can be useful in therapeutic treatment of skin cancer.
Result Analysis
Print
Save
E-mail